tiprankstipranks
Amphastar Pharmaceuticals Inc (AMPH)
NASDAQ:AMPH
US Market
AMPH
Amphastar Pharmaceuticals
RESEARCH TOOLSreports
Want to see AMPH full AI Analyst Report?

Amphastar Pharmaceuticals (AMPH) Stock Forecast & Price Target

432 Followers
See the Price Targets and Ratings of:

AMPH Analyst Ratings

Hold
6Ratings
Hold
0 Buy
6 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Amphastar
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMPH Stock 12 Month Forecast

Average Price Target

$22.00
▼(-3.85% Downside)
Based on 6 Wall Street analysts offering 12 month price targets for Amphastar Pharmaceuticals in the last 3 months. The average price target is $22.00 with a high forecast of $25.00 and a low forecast of $19.00. The average price target represents a -3.85% change from the last price of $22.88.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"$18","31":"$31","21.25":"$21.3","24.5":"$24.5","27.75":"$27.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$22.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$19.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,21.25,24.5,27.75,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.88,22.119999999999997,22.36,22.599999999999998,22.84,23.08,23.32,23.56,23.8,24.04,24.28,24.52,24.759999999999998,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.88,21.889230769230767,21.898461538461536,21.907692307692308,21.916923076923077,21.926153846153845,21.935384615384613,21.944615384615386,21.953846153846154,21.963076923076922,21.97230769230769,21.981538461538463,21.99076923076923,{"y":22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.88,21.658461538461538,21.436923076923076,21.215384615384615,20.993846153846153,20.77230769230769,20.55076923076923,20.32923076923077,20.107692307692307,19.886153846153846,19.664615384615384,19.443076923076923,19.22153846153846,{"y":19,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.88,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.38,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.34,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.21,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.99,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.45,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.78,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.92,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.01,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.24,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.88,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$25.00Average Price Target$22.00Lowest Price Target$19.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on AMPH
Benjamin Burnett
Wells Fargo
Wells Fargo
$30→$19
Hold
-16.96%
Downside
Downgraded
05/14/26
Amphastar downgraded to Equal Weight from Overweight at Wells FargoAmphastar downgraded to Equal Weight from Overweight at Wells Fargo
Piper Sandler Analyst forecast on AMPH
David Amsellem
Piper Sandler
Piper Sandler
$25→$21
Hold
-8.22%
Downside
Reiterated
05/11/26
Amphastar price target lowered to $21 from $25 at Piper SandlerAmphastar price target lowered to $21 from $25 at Piper Sandler
Needham Analyst forecast on AMPH
Serge Belanger
Needham
Needham
$30→
Hold
―
Downgraded
05/08/26
Needham downgrades Amphastar Pharmaceuticals (AMPH) to a Hold
Bank of America Securities Analyst forecast on AMPH
Chi Meng Fong
Bank of America Securities
Bank of America Securities
$28→$25
Hold
9.27%
Upside
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (NASDAQ: CAI), Amphastar Pharmaceuticals (NASDAQ: AMPH) and Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)
Jefferies Analyst forecast on AMPH
Dennis Ding
Jefferies
Jefferies
$30→$22
Hold
-3.85%
Downside
Downgraded
04/21/26
Amphastar downgraded to Hold from Buy at JefferiesAmphastar downgraded to Hold from Buy at Jefferies
Barclays Analyst forecast on AMPH
Glen Santangelo
Barclays
Barclays
$30→$23
Hold
0.52%
Upside
Assigned
04/07/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Tyra Bioscience (NASDAQ: TYRA) and Amphastar Pharmaceuticals (NASDAQ: AMPH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on AMPH
Benjamin Burnett
Wells Fargo
Wells Fargo
$30→$19
Hold
-16.96%
Downside
Downgraded
05/14/26
Amphastar downgraded to Equal Weight from Overweight at Wells FargoAmphastar downgraded to Equal Weight from Overweight at Wells Fargo
Piper Sandler Analyst forecast on AMPH
David Amsellem
Piper Sandler
Piper Sandler
$25→$21
Hold
-8.22%
Downside
Reiterated
05/11/26
Amphastar price target lowered to $21 from $25 at Piper SandlerAmphastar price target lowered to $21 from $25 at Piper Sandler
Needham Analyst forecast on AMPH
Serge Belanger
Needham
Needham
$30→
Hold
―
Downgraded
05/08/26
Needham downgrades Amphastar Pharmaceuticals (AMPH) to a Hold
Bank of America Securities Analyst forecast on AMPH
Chi Meng Fong
Bank of America Securities
Bank of America Securities
$28→$25
Hold
9.27%
Upside
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (NASDAQ: CAI), Amphastar Pharmaceuticals (NASDAQ: AMPH) and Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)
Jefferies Analyst forecast on AMPH
Dennis Ding
Jefferies
Jefferies
$30→$22
Hold
-3.85%
Downside
Downgraded
04/21/26
Amphastar downgraded to Hold from Buy at JefferiesAmphastar downgraded to Hold from Buy at Jefferies
Barclays Analyst forecast on AMPH
Glen Santangelo
Barclays
Barclays
$30→$23
Hold
0.52%
Upside
Assigned
04/07/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Tyra Bioscience (NASDAQ: TYRA) and Amphastar Pharmaceuticals (NASDAQ: AMPH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AMPH Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
3
5
3
4
1
Hold
5
4
3
3
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
9
6
7
8
In the current month, AMPH has received 1 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. AMPH average Analyst price target in the past 3 months is 22.00.
Each month's total comprises the sum of three months' worth of ratings.

AMPH Financial Forecast

AMPH Earnings Forecast

Next quarter’s earnings estimate for AMPH is $0.69 with a range of $0.55 to $0.79. The previous quarter’s EPS was $0.42. AMPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMPH has Performed in-line its overall industry.
Next quarter’s earnings estimate for AMPH is $0.69 with a range of $0.55 to $0.79. The previous quarter’s EPS was $0.42. AMPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMPH has Performed in-line its overall industry.

AMPH Sales Forecast

Next quarter’s sales forecast for AMPH is $180.34M with a range of $173.06M to $185.50M. The previous quarter’s sales results were $171.17M. AMPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMPH has Performed in-line its overall industry.
Next quarter’s sales forecast for AMPH is $180.34M with a range of $173.06M to $185.50M. The previous quarter’s sales results were $171.17M. AMPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMPH has Performed in-line its overall industry.

AMPH Stock Forecast FAQ

What is AMPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Amphastar Pharmaceuticals Inc’s 12-month average price target is 22.00.
    What is AMPH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for AMPH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is AMPH a Buy, Sell or Hold?
        Amphastar Pharmaceuticals Inc has a consensus rating of Hold which is based on 0 buy ratings, 6 hold ratings and 0 sell ratings.
          What is Amphastar Pharmaceuticals Inc’s price target?
          The average price target for Amphastar Pharmaceuticals Inc is 22.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $25.00 ,the lowest forecast is $19.00. The average price target represents -3.85% Decrease from the current price of $22.88.
            What do analysts say about Amphastar Pharmaceuticals Inc?
            Amphastar Pharmaceuticals Inc’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of AMPH?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.